Efficacy and safety of paclitaxel combined with cetuximab for head and neck squamous cell carcinoma
T Okada, I Okamoto, H Sato, T Ito, K Miyake… - in vivo, 2021 - iv.iiarjournals.org
Background/Aim: For recurrent/metastatic squamous cell carcinoma of the head and neck
(R/M SCCHN), popular regimens containing platinum-based anticancer agents and immune …
(R/M SCCHN), popular regimens containing platinum-based anticancer agents and immune …
Efficacy and Safety of Paclitaxel Combined With Cetuximab for Head and Neck Squamous Cell Carcinoma
T Okada, I Okamoto, H Sato, T Ito… - In vivo (Athens …, 2021 - pubmed.ncbi.nlm.nih.gov
Background/aim For recurrent/metastatic squamous cell carcinoma of the head and neck
(R/M SCCHN), popular regimens containing platinum-based anticancer agents and immune …
(R/M SCCHN), popular regimens containing platinum-based anticancer agents and immune …
[PDF][PDF] Efficacy and Safety of Paclitaxel Combined With Cetuximab for Head and Neck Squamous Cell Carcinoma
T OKADA, I OKAMOTO, H SATO, T ITO, K MIYAKE… - in vivo, 2021 - iv.iiarjournals.org
Background/Aim: For recurrent/metastatic squamous cell carcinoma of the head and neck
(R/M SCCHN), popular regimens containing platinum-based anticancer agents and immune …
(R/M SCCHN), popular regimens containing platinum-based anticancer agents and immune …
[HTML][HTML] Efficacy and Safety of Paclitaxel Combined With Cetuximab for Head and Neck Squamous Cell Carcinoma
T OKADA, I OKAMOTO, H SATO, T ITO, K MIYAKE… - In Vivo, 2021 - ncbi.nlm.nih.gov
Background/Aim: For recurrent/metastatic squamous cell carcinoma of the head and neck
(R/M SCCHN), popular regimens containing platinum-based anticancer agents and immune …
(R/M SCCHN), popular regimens containing platinum-based anticancer agents and immune …
Efficacy and Safety of Paclitaxel Combined With Cetuximab for Head and Neck Squamous Cell Carcinoma.
T Okada, I Okamoto, H Sato, T Ito, K Miyake… - In Vivo (Athens …, 2021 - europepmc.org
Results Thirty-eight patients were treated. The overall response and disease control rates of
first-line therapy were 43% and 79%, respectively, while those of second-line and later …
first-line therapy were 43% and 79%, respectively, while those of second-line and later …
Efficacy and Safety of Paclitaxel Combined With Cetuximab for Head and Neck Squamous Cell Carcinoma.
T OKADA, I OKAMOTO, H SATO, T ITO, K MIYAKE… - In …, 2021 - search.ebscohost.com
Abstract Background/Aim: For recurrent/metastatic squamous cell carcinoma of the head
and neck (R/M SCCHN), popular regimens containing platinum-based anticancer agents …
and neck (R/M SCCHN), popular regimens containing platinum-based anticancer agents …